Vaccines Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Vaccines Market to 2027 - Global Analysis and Forecasts By Type ( Monovalent and Multivalent ); Technology ( Recombinant Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines and Toxoid Vaccines ); Route of Administration ( Oral, Injectable and Other Routes of Administration )

Report Code: TIPRE00003424 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Vaccines are biological preparation which help in enhancing the immunity system towards a disease. A vaccine contains an agent that is similar to a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. Based on the antigens being used, vaccines are available in various forms. Some of the common disease indications for which vaccines are available are, pneumococcal disease, DTP, influenza, HPV, polio and hepatitis, among others.

MARKET DYNAMICS
The vaccines market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of infectious diseases as well as rising focus on immunization programs. In addition, focus on therapeutic vaccines and the use of adjuvants for developing vaccines is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of vaccines market with detailed market segmentation by type, technology, route of administration and geography. The global vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global vaccines market is segmented on the basis of type, technology and route of administration. Based on type, the market is segmented as monovalent and multivalent. The vaccines market, based on technology is segmented into recombinant vaccines, conjugate vaccines, live attenuated vaccines, inactivated and subunit vaccines and toxoid vaccines. On the basis of route of administration, the global vaccines market is segmented into, oral, injectable and other routes of administration.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global vaccines market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The vaccines market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting vaccines market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the vaccines market in these regions.

MARKET PLAYERS
The reports cover key developments in the vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for vaccines market in the global market. Below mentioned is the list of few companies engaged in the vaccines market.

The report also includes the profiles of key vaccines market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Pfizer
• Glaxosmithkline
• Merck
• Sanofi Pasteur
• Johnson & Johnson
• Panacea Biotec
• Astellas Pharma
• Serum Institute of India
• Emergent Biosolutions
• CSL Limited

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Vaccines Market - By Type
1.3.2 Vaccines Market - By Technology
1.3.3 Vaccines Market - By Route of Administration
1.3.4 Vaccines Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.3.1 North America - Pest Analysis
4.3.2 Europe - Pest Analysis
4.3.3 Asia-Pacific - Pest Analysis
4.3.4 Middle East and Africa - Pest Analysis
4.3.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. VACCINES MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. VACCINES MARKET - GLOBAL MARKET ANALYSIS

6.1. VACCINES - GLOBAL MARKET OVERVIEW
6.2. VACCINES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE

7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOVALENT
7.3.1. Overview
7.3.2. Monovalent Market Forecast and Analysis
7.4. MULTIVALENT
7.4.1. Overview
7.4.2. Multivalent Market Forecast and Analysis

8. VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY

8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. RECOMBINANT VACCINES
8.3.1. Overview
8.3.2. Recombinant Vaccines Market Forecast and Analysis
8.4. CONJUGATE VACCINES
8.4.1. Overview
8.4.2. Conjugate Vaccines Market Forecast and Analysis
8.5. LIVE ATTENUATED VACCINES
8.5.1. Overview
8.5.2. Live Attenuated Vaccines Market Forecast and Analysis
8.6. INACTIVATED AND SUBUNIT VACCINES
8.6.1. Overview
8.6.2. Inactivated and Subunit Vaccines Market Forecast and Analysis
8.7. TOXOID VACCINES
8.7.1. Overview
8.7.2. Toxoid Vaccines Market Forecast and Analysis

9. VACCINES MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION

9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INJECTABLE
9.4.1. Overview
9.4.2. Injectable Market Forecast and Analysis
9.5. OTHER ROUTES OF ADMINISTRATION
9.5.1. Overview
9.5.2. Other Routes of Administration Market Forecast and Analysis

10. VACCINES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Vaccines Market Overview
10.1.2 North America Vaccines Market Forecasts and Analysis
10.1.3 North America Market Forecasts and Analysis - By Type
10.1.4 North America Market Forecasts and Analysis - By Technology
10.1.5 North America Market Forecasts and Analysis - By Route of Administration
10.1.6 North America Market Forecasts and Analysis - By Countries
10.1.6.1 United States Market
10.1.6.1.1 United States Market by Type
10.1.6.1.2 United States Market by Technology
10.1.6.1.3 United States Market by Route of Administration
10.1.6.2 Canada Market
10.1.6.2.1 Canada Market by Type
10.1.6.2.2 Canada Market by Technology
10.1.6.2.3 Canada Market by Route of Administration
10.1.6.3 Mexico Market
10.1.6.3.1 Mexico Market by Type
10.1.6.3.2 Mexico Market by Technology
10.1.6.3.3 Mexico Market by Route of Administration
10.2. EUROPE
10.2.1 Europe Vaccines Market Overview
10.2.2 Europe Vaccines Market Forecasts and Analysis
10.2.3 Europe Market Forecasts and Analysis - By Type
10.2.4 Europe Market Forecasts and Analysis - By Technology
10.2.5 Europe Market Forecasts and Analysis - By Route of Administration
10.2.6 Europe Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Market
10.2.6.1.1 Germany Market by Type
10.2.6.1.2 Germany Market by Technology
10.2.6.1.3 Germany Market by Route of Administration
10.2.6.2 France Market
10.2.6.2.1 France Market by Type
10.2.6.2.2 France Market by Technology
10.2.6.2.3 France Market by Route of Administration
10.2.6.3 Italy Market
10.2.6.3.1 Italy Market by Type
10.2.6.3.2 Italy Market by Technology
10.2.6.3.3 Italy Market by Route of Administration
10.2.6.4 Spain Market
10.2.6.4.1 Spain Market by Type
10.2.6.4.2 Spain Market by Technology
10.2.6.4.3 Spain Market by Route of Administration
10.2.6.5 United Kingdom Market
10.2.6.5.1 United Kingdom Market by Type
10.2.6.5.2 United Kingdom Market by Technology
10.2.6.5.3 United Kingdom Market by Route of Administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Vaccines Market Overview
10.3.2 Asia-Pacific Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Market Forecasts and Analysis - By Technology
10.3.5 Asia-Pacific Market Forecasts and Analysis - By Route of Administration
10.3.6 Asia-Pacific Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Market
10.3.6.1.1 Australia Market by Type
10.3.6.1.2 Australia Market by Technology
10.3.6.1.3 Australia Market by Route of Administration
10.3.6.2 China Market
10.3.6.2.1 China Market by Type
10.3.6.2.2 China Market by Technology
10.3.6.2.3 China Market by Route of Administration
10.3.6.3 India Market
10.3.6.3.1 India Market by Type
10.3.6.3.2 India Market by Technology
10.3.6.3.3 India Market by Route of Administration
10.3.6.4 Japan Market
10.3.6.4.1 Japan Market by Type
10.3.6.4.2 Japan Market by Technology
10.3.6.4.3 Japan Market by Route of Administration
10.3.6.5 South Korea Market
10.3.6.5.1 South Korea Market by Type
10.3.6.5.2 South Korea Market by Technology
10.3.6.5.3 South Korea Market by Route of Administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Vaccines Market Overview
10.4.2 Middle East and Africa Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Market Forecasts and Analysis - By Technology
10.4.5 Middle East and Africa Market Forecasts and Analysis - By Route of Administration
10.4.6 Middle East and Africa Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Market
10.4.6.1.1 South Africa Market by Type
10.4.6.1.2 South Africa Market by Technology
10.4.6.1.3 South Africa Market by Route of Administration
10.4.6.2 Saudi Arabia Market
10.4.6.2.1 Saudi Arabia Market by Type
10.4.6.2.2 Saudi Arabia Market by Technology
10.4.6.2.3 Saudi Arabia Market by Route of Administration
10.4.6.3 U.A.E Market
10.4.6.3.1 U.A.E Market by Type
10.4.6.3.2 U.A.E Market by Technology
10.4.6.3.3 U.A.E Market by Route of Administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Vaccines Market Overview
10.5.2 South and Central America Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Market Forecasts and Analysis - By Type
10.5.4 South and Central America Market Forecasts and Analysis - By Technology
10.5.5 South and Central America Market Forecasts and Analysis - By Route of Administration
10.5.6 South and Central America Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Market
10.5.6.1.1 Brazil Market by Type
10.5.6.1.2 Brazil Market by Technology
10.5.6.1.3 Brazil Market by Route of Administration
10.5.6.2 Argentina Market
10.5.6.2.1 Argentina Market by Type
10.5.6.2.2 Argentina Market by Technology
10.5.6.2.3 Argentina Market by Route of Administration

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. VACCINES MARKET, KEY COMPANY PROFILES

12.1. PFIZER
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. MERCK
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI PASTEUR
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON & JOHNSON
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PANACEA BIOTEC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ASTELLAS PHARMA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SERUM INSTITUTE OF INDIA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EMERGENT BIOSOLUTIONS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. CSL LIMITED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer
2. Glaxosmithkline
3. Merck
4. Sanofi Pasteur
5. Johnson & Johnson
6. Panacea Biotec
7. Astellas Pharma
8. Serum Institute of India
9. Emergent Biosolutions
10. CSL Limited
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book